Rx Bandz announce that it has been awarded an SBIR contract with the US Military to develop its MiniJect® auto-injector for epinephrine. According to the Military Health Agency, more military men and women died of anaphylaxis in five years than died in the Iraq-Afghanistan wars in 10 years.
Jessica Walsh, CEO of Rx Bandz, said, “We are honored that the Air Force recognizes that severe reaction to allergies occurs in thousands of warfighters. The Air Force screens out people with severe allergies in its recruitment; however, about 40 percent of anaphylaxis occurs in people who never experienced severe reactions. We will develop our MiniJect® auto-injector specifically for military requirements.”